Search published articles


Showing 3 results for Eghdam Zamiri

M Jamehshorani, R Eghdam Zamiri, M Moghimi,
Volume 20, Issue 78 (3-2012)
Abstract

Gastric cancer is one of the most common cancers in the world that can metastasize to other sites. The most common sites of metastasis are liver, lung, bone, and adrenal glands. Skin metastasis in gastric cancer is rare, and it usually occurs after diagnosis of primary cancer (1). The patient reported here is a 65-years old male with gastric adenocarcinoma that in the course of chemotherapy came down with some skin lesions. The biopsy report points to skin metastasis from gastric cancer. In spite of good systemic response to chemotherapy, the lesions progressed. Skin metastasis has poor prognosis, and it is a sign of disease diffusion (2).


R Eghdam Zamiri, M Moghimi, N Mosavi Nasab, H Amirmoghadami, M Joghatae , A Feizi,
Volume 20, Issue 81 (9-2012)
Abstract

Background and Objective: Elevation of the b-HCG serum levels has been reported in several tumors including breast cancer, and it is usually associated with aggressiveness. The aim of this study was to examine the possible correlation between the b-HCG serum levels and different grades of breast cancer tumors in patients undergoing chemotherapy. Materials and Methods: This cross-sectional study was conducted in the city of Zanjan during 2009-10. Serum samples from 56 cases of breast cancer patients were collected after surgery and prior to chemotherapy for analysis of total free b-HCG by electro chemiluminescence immunoassay, and the same procedure was repeated after 8 courses of chemotherapy. The b-HCG serum levels were compared in poor versus mild to moderate grades before and after chemotherapy. Results: In 37 cases of mild to moderate grade tumors, the mean b-HCG level was 1.09 ±1.4 miu/ml compared with 1.2 ±0.3 miu/ml (P= 0.75) in 29 cases of poor grade tumors. The mean b-HCG levels before and after chemotherapy were 1.15 ±1.4 miu/ml and 1.17 ±1.4 miu/ml (P=0.24), respectively. Conclusion: We did not find any significant association between the b-HCG serum levels and breast cancer tumor grades. Furthermore, chemotherapy does not appear to have an effect on b-HCG serum levels.


R Eghdam Zamiri , Sh Shokoufi, Z Ghadimi, Ss Baba Ali, S Jafari, B Talebi Pour, M Nazarian, S Palizi , M Moghimi,
Volume 23, Issue 101 (8-2015)
Abstract

Background and Objective: Upper gastro intestinal cancers are considered to be a global health problem and gastric cancer is the fourth common malignancy worldwide. In cancer patients, low levels of albumin,
C-reactive protein and platelets are considered as bad prognostic factors. The objective of this study was to evaluate the levels of Albumin (Alb), C-reactive protein (CRP), and Platelets in patients admitted to Endoscopy Unit of Vali-e-Asr Hospital in Zanjan in 2011-2012.

Materials and Methods: 308 patients who had been admitted for upper gasterointestinal endoscopy to Endoscopy Unit of Vali-e-Asr Hospital in Zanjan were entered into this study. Through the upper endoscopy of all abnormal lesions went through biopsy and pathological studies were followed.

Results: Patients were assigned to three groups of normal, benign and malignant lesions and their platelets, albumin levels, BMI and C-reactive protein were measured and compared as prognostic factors. The mean BMI, in the malignant group was significantly lower than the other two groups) PV=0.051(. The mean values of serum albumin in the malignant group was significantly lower than the other two groups (PV=0.023). Meanwhile, the average level of CRP and platelets in the malignant group was significantly higher than the other two groups.  

Conclusion: Due to the high prevalence of gastrointestinal malignancies in Iran, measurement of albumin, C-reactive protein and platelet levels can be an efficient approach to diagnose or prognosis in these diseases.



Page 1 from 1     

© 2020 All Rights Reserved | J Adv Med Biomed Res

Designed & Developed by : Yektaweb  Co-Publisher: Farname Inc.